Gregory W. Mattingly, MD, is an Associate Clinical Professor of Psychiatry and has been a Psychopharmacology Instructor for over twenty years at The Washington University School of Medicine in St. Louis, Missouri. He earned his medical degree and completed his residency at Washington University, where he received a Fulbright Scholarship. Dr. Mattingly has been a principal investigator in more than 500 clinical trials and his research has been published in numerous national and international journals.
In addition to his clinical and research practice, Dr. Mattingly worked as a consultant and evaluator for the National Football League and Major League Baseball.
Dr. Mattingly is the Past-President for the American Professional Society for ADHD and Related Disorders, is the CMO of ACCUMIN Neuroscience, serves on the Scientific Program Committee for the World Federation for ADHD and is Co-Chair for the US Psych Congress.